Modulatory effect of high saturated fat diet-induced metabolic disturbances on angiogenic response in hepatocyte RXRα knockout mice

Pharmacological Reports

Volumn 62, Issue 6, 2010, Pages 1078-1089

  Raźny, Urszula ^a   Wa̧tor, Łukasz ^a   Polus, Anna ^a   Kieć Wilk, Beata ^a   Wan, Yu Jui Yvonne ^b   Dyduch, Grzegorz ^a   Tomaszewska, Romana ^a   Dembińska Kieć, Aldona ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Adipogenesis; Angiogenesis; Apoptosis; Metabolic syndrome; Microarray; RXR ko

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; CASPASE 3; CD31 ANTIGEN; CHOLESTEROL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBROBLAST GROWTH FACTOR; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; LEPTIN; MATRIGEL; PROTEIN BCL 2; RETINOID X RECEPTOR ALPHA; SATURATED FATTY ACID; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOWN REGULATION; DYSLIPIDEMIA; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPERLEPTINEMIA; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; LIPID DIET; MALE; METABOLIC DISORDER; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 79551484194     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(10)70370-4     Document Type: Article

References (35)

1. Ahmad S, Hewett PW, Wang P, Al-Ani B, Cudmore M, Fujisawa T, Haigh JJ et al.: Direct evidence for endothelial vascular endothelial growth factor receptor-1 function in nitric oxide-mediated angiogenesis. Circ Res, 2006, 99, 715-722. (Pubitemid 44498305)
2. Ambati S, Kim H-K, Yang J, Lin J, Della-Fera M, Baile C: Effects of leptin on apoptosis and adipogenesis in 3T3-L1 adipocytes. Biochem Pharmacol, 2007, 73, 378-384. (Pubitemid 44958368)
3. Chinen I, Shimabukuro M, Yamakawa K, Higa N, Matsuzaki T, Noguchi K, Ueda S et al.: Vascular lipotoxicity: endothelial dysfunction via fatty-acid-induced reactive oxygen species overproduction in obese Zucker diabetic fatty rats. Endocrinology, 2007, 148, 160-165. (Pubitemid 46021448)
4. Clarke SD, Thuillier P, Baillie RA, Sha X: Peroxisome proliferator-activated receptors: a family of lipid-activated transcription factors. Am J Clin Nutr, 1999, 70, 566-571.
5. Dembinska-Kiec A, Dulak J, Partyka L, Krzesz R, Dudek D, Bartus S, Polus M et al.: Induction of nitric oxide synthase (NOS) and vascular endothelial growth factor (VEGF) in experimental model of angioplasty and heart ischemia. Adv Exp Med Biol, 1997, 433, 163-167.
6. Fève B: Adipogenesis: cellular and molecular aspect. Best Pract Res Clin Endocrinol Metab, 2005, 19, 483-499.
7. Gupta K, Zhang J: Angiogenesis: a curse or cure? Postgrad Med J, 2005, 81, 236-242.
8. Hansel B, Giral P, Nobecourt E, Chantepie S, Bruckert E, Chapman MJ, Kontush A: Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab, 2004, 89, 4963-4971.
9. Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M: High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes, 2000, 49, 1939-1945.
10. Kawasaki S, Hasegawa O, Satoh S, Saito T, Ishio H, Fukushima H, Kato S et al.: Development and progression of retinopathy after inpatient management of diabetes. Intern Med, 2006, 45, 1267-1271.
11. Kiec-Wilk B, Dembinska-Kiec A, Olszanecka A, Bodzioch M, Kawecka-Jaszcz K: The selected pathophysiological aspects of PPARs activation. J Physiol Pharmacol, 2005, 56, 149-162.
12. Kim KY, Cheon HG: Antiangiogenic effect of rosiglitazone is mediated via peroxisome proliferator-activated receptor γ-activated maxi-K channel opening in human umbilical vein endothelial cells. J Biol Chem, 2006, 281, 13503-13512.
13. Kraml P, Syrovatka P, Stipek S, Fialova L, Koprivova H, Potockova J, Andel M: Hyperlipoproteinemia impairs endothelium-dependent vasodilation. Physiol Res, 2004, 53, 471-480.
14. Lee TS, Saltsman KA, Ohashi H, King GL: Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications. Proc Natl Acad Sci USA, 1989, 86, 5141-5145.
15. Massiera F, Saint-Marc P, Seydoux J, Murata T, Kobayashi T, Narumiya S, Guesnet P et al.: Arachidonic acid and prostacyclin signaling promote adipose tissue development: a human health concern? J Lipid Res, 2003, 44, 271-279.
16. Matsumoto T, Mugishima H: Signal transduction via vascular endothelial growth factor (VEGF) receptors and their roles in atherogenesis. J Atheroscler Thromb, 2006, 13, 130-135.
17. McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G: Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med, 2003, 139, 802-809.
18. Nishimura S, Manabe I, Nagasaki M, Hosoya Y, Yamashita H, Fujita H, Ohsugi M et al.: Adipogenesis in obesity requires close interplay between differentiating adipocytes, stromal cells, and blood vessels. Diabetes, 2007, 56, 1517-1526.
19. Oliveros LB, Videla AM, Gimenez MS: Effect of dietary fat saturation on lipid metabolism, arachidonic acid turnover and peritoneal macrophage oxidative stress in mice. Braz J Med Biol Res, 2004, 37, 311-320.
20. Papetti M, Herman IM: Mechanisms of normal and tumor-derived angiogenesis. Am J Physiol Cell Physiol, 2002, 282, 947-970.
21. Park HY, Kwon HM, Lim HJ, Hong BK, Lee JY, Park BE, Jang Y et al.: Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Exp Mol Med, 2001, 33, 95-102.
22. Parvanova A, Iliev I, Filipponi M, Dimitrov BD, Vedovato M, Tiengo A, Trevisan R et al.: Insulin resistance and proliferative retinopathy: a cross-sectional, case-control study in 115 patients with type 2 diabetes. J Clin Endocrinol Metab, 2004, 89, 4371-4376.
23. Polverini PJ: Angiogenesis in health and disease: insights into basic mechanisms and therapeutic opportunities. J Dent Educ, 2002, 66, 962-975.
24. Scarfo LM, Weller PF, Farber HW: Induction of endothelial cell cytoplasmic lipid bodies during hypoxia. Am J Physiol Heart Circ Physiol, 2001, 280, 294-301.
25. Stitt AW, Curtis TM: Advanced glycation and retinal pathology during diabetes. Pharmacol Rep, 2005, 57, 156-168.
26. Sun XM, Bratton SB, Butterworth M, MacFarlane M, Cohen GM: Bcl-2 and Bcl-xL inhibit CD95-mediated apoptosis by preventing mitochondrial release of Smac/DIABLO and subsequent inactivation of X-linked inhibitor-of-apoptosis protein. J Biol Chem, 2002, 277, 11345-11351.
27. Tei K, Kawakami-Kimura N, Taguchi O, Kumamoto K, Higashiyama S, Taniguchi N, Toda K et al.: Roles of cell adhesion molecules in tumor angiogenesis induced by cotransplantation of cancer and endothelial cells to nude rats. Cancer Res, 2002, 62, 6289-6296.
28. Vidal-Puig A, Rosenbaum M, Considine RC, Leibel RL, Dohm GL, Lowell BB: Effects of obesity and stable weight reduction on UCP2 and UCP3 gene expression in humans. Obes Res, 1999, 7, 133-140.
29. Villarroya F, Iglesias R, Giralt M: Retinoids and retinoid receptors in the control of energy balance: novel pharmacological strategies in obesity and diabetes. Curr Med Chem, 2004, 11, 795-805.
30. Vucenik I, Passaniti A, Vitolo MI, Tantivejkul K, Eggleton P, Shasuddin AM: Anti-angiogenic activity of inositol hexaphosphate (IP6). Carcinogenesis, 2004, 11, 2115-2123.
31. Wan YJ, An D, Cai Y, Repa JJ, Hung-Po, Chen T, Flores M et al.: Hepatocyte-specific mutation establishes retinoid X receptor α as a heterodimeric integrator of multiple physiological processes in the liver. Mol Cell Biol, 2000, 20, 4436-4444.
32. Wan YJ, Cai Y, Lungo W, Fu P, Locker J, French S, Sucov HM: Peroxisome proliferator-activated receptor α-mediated pathways are altered in hepatocyte-specific retinoid X receptor α-deficient mice. J Biol Chem, 2000, 275, 28285-28290.
33. Wan YJ, Han G, Cai Y, Dai T, Konishi T, Leng AS: Hepatocyte retinoid X receptor-α-deficient mice have reduced food intake, increased body weight, and improved glucose tolerance. Endocrinology, 2003, 144, 605-611.
34. West CML, Cooper RA, Loncaster JA, Wilks DP, Bromley M: Tumor vascularity: a histological measure of angiogenesis and hypoxia. Cancer Res, 2001, 61, 2907-2910.
35. Zeng G, Gao L, Birkle S, Yu RK: Suppression of ganglioside GD3 expression in rat F-11 tumor cell line reduces tumor growth, angiogenesis, and vascular endothelial growth factor production. Cancer Res, 2000, 23, 6670-6676.